PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN THE ACE INHIBITOR CILAZAPRIL AND BETA-ADRENOCEPTOR ANTAGONIST PROPRANOLOL IN HEALTHY-SUBJECTS AND IN HYPERTENSIVE PATIENTS

被引：7
作者：
BELZ, GG
ESSIG, J
ERB, K
BREITHAUPT, K
HOOGKAMER, JFW
KNEER, J
KLEINBLOESEM, CH
机构：
[1] ZE KA PHA GMBH,ZENTRUM KARDIOVASC PHARMAKOL,WIESBADEN,FED REP GER
[2] HOFFMANN LA ROCHE LTD,DEPT CLIN RES,BASEL,SWITZERLAND
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 27卷
关键词：
D O I：
10.1111/j.1365-2125.1989.tb03498.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S317 / S322
页数：6
相关论文
共 50 条
  • [1] HEMODYNAMIC AND HORMONAL EFFECTS OF CILAZAPRIL IN COMPARISON WITH PROPRANOLOL IN HEALTHY-SUBJECTS AND IN HYPERTENSIVE PATIENTS
    KLEINBLOESEM, CH
    ERB, K
    ESSIG, J
    BREITHAUPT, K
    BELZ, GG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 : S309 - S315
  • [2] EFFECTS OF A BETA-ADRENOCEPTOR ANTAGONIST ON THE RESPONSES TO TILTING IN HYPERTENSIVE SUBJECTS
    ALSHAMMA, YMH
    WORTH, DP
    HAINSWORTH, R
    CLINICAL SCIENCE, 1985, 68 : P68 - P68
  • [3] PHARMACODYNAMIC WITHOUT PHARMACOKINETIC INTERACTION BETWEEN CICLOPROLOL, A PARTIAL BETA-1-ADRENOCEPTOR AGONIST, AND DIGOXIN IN HEALTHY-SUBJECTS
    WEBER, S
    KAHAN, A
    PINQUIER, JL
    JULIEN, J
    ROSENZWEIG, P
    BIANCHETTI, G
    MORSELLI, PL
    DESSAULT, O
    DELAUTURE, D
    STRAUCH, G
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (03) : 411 - 416
  • [4] LACK OF PHARMACODYNAMIC AND PHARMACOKINETIC INTERACTIONS OF THE ANTIHISTAMINE EBASTINE WITH ETHANOL IN HEALTHY-SUBJECTS
    MATTILA, MJ
    KUITUNEN, T
    PLETAN, Y
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (02) : 179 - 184
  • [5] THE INTERACTIONS BETWEEN NISOLDIPINE AND 2 BETA-ADRENOCEPTOR ANTAGONISTS - ATENOLOL AND PROPRANOLOL
    ELLIOTT, HL
    MEREDITH, PA
    MCNALLY, C
    REID, JL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (03) : 379 - 385
  • [6] BOPINDOLOL, A NEW LONG-ACTING BETA-ADRENOCEPTOR ANTAGONIST - A RANDOMIZED COMPARISON AGAINST PROPRANOLOL IN HYPERTENSIVE PATIENTS
    KIRCH, W
    AXTHELM, T
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1983, 3 (02) : 89 - 93
  • [7] HUMAN PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES ON RO31-1118, A NEW BETA-ADRENOCEPTOR ANTAGONIST
    OCONNOR, PC
    ARNOLD, JMO
    BROWN, AN
    FRANCIS, RJ
    FINCH, MB
    GALLOWAY, DB
    HARRON, DWG
    MCDEVITT, DG
    SHANKS, RG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (03) : 319 - 327
  • [8] Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram in healthy subjects
    Berger, Benjamin
    Kornberger, Ruediger
    Dingemanse, Jasper
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 51 : 90 - 104
  • [9] STUDIES INVIVO AND INVITRO OF TERBUTALINE-INDUCED BETA-ADRENOCEPTOR DESENSITIZATION IN HEALTHY-SUBJECTS
    MARTINSSON, A
    LARSSON, K
    HJEMDAHL, P
    CLINICAL SCIENCE, 1987, 72 (01) : 47 - 54
  • [10] EVALUATION OF POTENTIAL PHARMACODYNAMIC AND PHARMACOKINETIC INTERACTIONS BETWEEN VERAPAMIL AND PROPRANOLOL IN NORMAL SUBJECTS
    MURDOCH, DL
    THOMSON, GD
    THOMPSON, GG
    MURRAY, GD
    BRODIE, MJ
    MCINNES, GT
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (03) : 323 - 332
12345